SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-114222
Filing Date
2024-11-05
Accepted
2024-11-05 12:42:38
Documents
1
Period of Report
2024-09-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2427444-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2427444-1_4seq1.xml 4 39832
  Complete submission text file 0001104659-24-114222.txt   41590
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Issuer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE BOW STREET CAMBRIDGE MA 02138
Business Address
Cherington Charles (Reporting) CIK: 0001448698 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11460 | Film No.: 241426553